Saratov JOURNAL of Medical and Scientific Research

Prospective study of patients with old myocardial infarction: influence of presence or absence of type 2 diabetes mellitus on adherence to treatment

Year: 2019, volume 15 Issue: №3 Pages: 791-796
Heading: Cardiology Article type: Original article
Authors: Naumova Е.А., Bulaeva Yu.V., Semenova O.N.
Organization: Saratov State Medical University

The purpose of the study is to conduct a prospective study of patients with old myocardial infarction with the presence or absence of type 2 diabetes mellitus and to identify factors associated on adherence to therapy. Material and Methods. 80 hospitalized patients with old myocardial infarction were included into the study: group one with type 2 diabetes mellitus (50%), group two — without it (50%). Standard clinical, laboratory and instrumental examination, calculation of metabolic indices were performed. 6 months discharge by phone viewed the continuation and regularity of therapy, end points. Results. The results of a study regarding adherence to therapy were evaluated over the phone 6 months after discharge from hospital; factors associated with continuation of therapy are presented. Conclusion. Patients with old myocardial infarction and diabetes mellitus are more adherents to treatment. Increased waist circumference, patient satisfaction with therapy, low rate of re-hospitalization and positive emotional evaluation of aspects of the therapy are factors is associated with high adherence to therapy.

1 Simon-Tuval T, et al. The association between adherence to cardiovascular medications and healthcare utilization. Eur J Health Econ 2016; 17 (5): 603-10.
2 Choudhry NK, Glynn RJ, Avorn J, et al. Untangling the relationship between medication adherence and post- myocardial infarction outcomes. Am Heart J 2014; (167): 51 -8
3 Puchinyan NF, Dovgalevskiy YaP, Dolotovskaya PV, Furman NV. The adherence to recommended therapy in patients after acute coronary syndrome, and risk of cardiovascular complications within a year after hospital admission. Rational Pharmacotherapy in Cardiology 2011; 7 (5): 567-73.
4 Lukina YuV, Kutishenko NP, Dmitrieva NA, Martsevich SYu. Compliance to clinician prescriptions in iscnemic heart disease patients (by the data from outpatient registry PROFILE). Russian Journal of Cardiology 2017; (3): 14-9.
5 Naumova ЕА, Tarasenko EV, Shvarts YuG. The influence of standard clear motivated recommendations on the patient's compliance to long-term therapy. International Medical Journal 2007; (1): 123-29.
6 Likhodey NV, Kalashnikova MF, Likhodey EM, Fadeev VV. Analysis of the factors that prevent adherence to treatment in patients with diabetes mellitus and the strategies that contribute to the improvement in adherence. Diabetes mellitus 2018; 21 (1): 5-14.
7 Adamek КЕ, Ramadurai D, Gunzburger Е, et al. Association of Diabetes Mellitus Status and Glycemic Control with Secondary Prevention Medication Adherence after Acute Myocardial Infarction. JAm Heart Assoc 2019; 8 (3): e011448.
8 Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34 (39): 3035-87.
9 Abdellatif AM, Shishova ТА. Metabolic syndrome and its effect on cardiovascular complications in patients with acute coronary syndrome. Problems of modern science and education 2015; 1 (1). URL: http://science- d=17911 (11 Sep 2019).
10 Diagnostics and correction of lipid metabolism disorders in order to prevent and treatment atherosclerosis: Russian recommendations, 6th ed. Moscow, 2017; p. 44
11 The Guidelines of Society of Cardiology of the Russian Federation on diagnosis and treatment of the metabolic syndrome, 2nd ed. Cardiovascular therapy and prevention 2009; 8 (6).
12 Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus (WHO/NCD/NCS/99.2). Geneva: World Health Organization, 1999

2019_03-1_791-796.pdf422.87 KB

No votes yet